Guilherme G. Moreira is a PhD Student at Protein Misfolding and Amyloids in Biomedicine (PMAB) group (http://folding.fc.ul.pt) at Faculty of Sciences of the University of Lisbon and affiliated to BioISI Biosystems & Integrative Sciences Institute. Born in 1995, has graduated in Biochemistry (2016) and completed his master's in Medical Biochemistry (2018) at the University of Lisbon. Guilherme started his PhD studies with an FCT PhD Studentship on the PMAB GomesLab (2021) with the project entitled The calcium-binding protein S100B as a novel chaperone preventing Tau aggregation in Alzheimer's disease. Guilherme is the first author of 3 published peer-reviewed international papers (2019, 2021 and 2023), co-author of 1 published book chapter (2020) and co-author of 2 published peer-reviewed international paper (2021 and 2022), as well as author of 19 posters and 5 oral communications presented in national and international events. Has been awarded 6 travel/accommodation and registration awards for international meetings. Research Identifiers Google Scholar: https://scholar.google.com/citations?user=https://scholar.google.com/citations?user=BTcYDiYAAAAJ&hl=pt-PT&user=BTcYDiYAAAAJ Scopus: https://www.scopus.com/authid/detail.uri?authorId=57212030809 ORCID: https://orcid.org/0000-0003-4791-5403 Web Of Science: https://www.webofscience.com/wos/author/record/B-6154-2018

I obtained my PhD in plant molecular biology from the University of Nottingham and have spent the past 30 years in science publishing. I've worked for various journals, including Nature and Trends in Biochemical Sciences, and also edited many books. I was the Executive Editor of FEBS Open Bio from its launch in 2011 until 2019.

Nanotechnology, drug delivery systems, biosensors, chromatography, advanced materials characterization

Dr. Isabel Varela-Nieto graduated and earned her doctorate in Chemistry, Biochemistry Section, at the University Complutense of Madrid (Spain). She has been a visiting guest scientist at the Medical Schools of Uppsala (FEBS Fellow, Sweden) and San Diego (MEC Sabbatical, USA). She is Professor of Research at the CSIC and group leader at the CIBER of rare diseases (CIBERER, ISCIII) in Madrid. From the early 1990s she has been studying hearing neurobiology and IGF-1 actions. She was the first Chair of the SEBBM Science for Society working group with which she actively collaborates, and member of the FEBS Network working group. She is currently the president of the SEBBM, a member of the FEBS Science and Society Committee and of the ISC Finances Committee.

The FEBS Journal is an international journal devoted to the rapid publication of full-length papers covering a wide range of topics in any area of the molecular life sciences.